Phase I/II Comparison of Efficacy and Safety of BIBF 1120 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma
Clinical trial NCT01004003 · COMPLETED
Trial details
- NCT number
- NCT01004003
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-22
- Primary completion
- 2014-07-14
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.